Alkem Laboratories Limited (ALKEM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Alkem Laboratories Limited (NSE: ALKEM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 200, NIFTY 500, NIFTY Healthcare Index. As of 21 Sep 2026, the share price was ₹5,466.00, market capitalisation ₹65,360 Cr, P/E 28.8, ROE 18.9%.
Get the AI verdict on ALKEM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
ALKEM price and valuation
- Share price
- ₹5,466.00
- Market cap
- ₹65,360 Cr
- P/E ratio
- 28.8
- P/B ratio
- 4.73
- EPS
- ₹180.45
- Book value per share
- ₹1,156.00
- Dividend yield
- 0.97%
ALKEM profitability and growth
- ROE
- 18.9%
- ROCE
- 21.2%
- Debt to equity
- 0.14
- Revenue growth (3 yr)
- 8%
- Revenue growth (5 yr)
- 11%
- Profit growth (3 yr)
- 32%
- Profit growth (5 yr)
- 9%
ALKEM 52-week range
- 52-week high
- ₹5,933.50
- 52-week low
- ₹5,051.00
- Face value
- ₹2.00
ALKEM shareholding pattern
- Promoters
- 49.7%
- FIIs
- 10.42%
- DIIs
- 22.64%
- Public
- 17.25%
Index membership: NIFTY 200, NIFTY 500, NIFTY Healthcare Index, NIFTY Midcap 100, NIFTY Midcap 150, NIFTY Midcap 50, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.